Literature DB >> 2757897

A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitro.

R J Riley1, C Lambert, N R Kitteringham, B K Park.   

Abstract

1. The metabolism of the enantiomers of mianserin to stable, chemically reactive and cytotoxic metabolites by human liver microsomes has been investigated in vitro. 2. Both enantiomers were metabolised to three major oxidation products: 8-hydroxymianserin, desmethylmianserin and mianserin 2-oxide. Hydroxylation occurred more readily with the S-enantiomer, whereas desmethylmianserin was always the major metabolite of the R-enantiomer. 3. The generation of chemically reactive metabolites exhibited a marginal degree of stereoselectivity, as assessed by irreversible binding of drug to microsomal protein (S greater than or equal to R; P less than or equal to 0.05). 4. The formation of metabolites which were cytotoxic towards human mononuclear leucocytes was greater (P less than or equal to 0.001] for R(-)-mianserin than for S(+)-mianserin and showed a significant correlation with N-demethylation (r = 0.84, P less than or equal to 0.01).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757897      PMCID: PMC1379810          DOI: 10.1111/j.1365-2125.1989.tb03445.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  31 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  SERUM LACTIC DEHYDROGENASE ACTIVITY: AN ANALYTICAL ASSESSMENT OF CURRENT ASSAYS.

Authors:  E AMADOR; L E DORFMAN; W E WACKER
Journal:  Clin Chem       Date:  1963-08       Impact factor: 8.327

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Irreversible protein binding of [14-C]imipramine with rat and human liver microsomes.

Authors:  H Kappus; H Remmer
Journal:  Biochem Pharmacol       Date:  1975-05-15       Impact factor: 5.858

5.  The metabolism of mianserin in women, rabbits, and rats: identification of the major urinary metabolites.

Authors:  G D de Jongh; H M van den Wildenberg; H Nieuwenhuyse; F van der Veen
Journal:  Drug Metab Dispos       Date:  1981 Jan-Feb       Impact factor: 3.922

Review 6.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

7.  Acetaminophen toxicity in human lymphocytes in vitro.

Authors:  S P Spielberg
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

8.  Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.

Authors:  A R Boobis; M J Brodie; G C Kahn; D R Fletcher; J H Saunders; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

9.  Toxic agents resulting from the oxidative metabolism of steroid hormones and drugs.

Authors:  E C Horning; J P Thenot; E D Helton
Journal:  J Toxicol Environ Health       Date:  1978 Mar-May

10.  An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.

Authors:  R J Riley; J L Maggs; C Lambert; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

View more
  3 in total

Review 1.  Formation of active metabolites of psychotropic drugs. An updated review of their significance.

Authors:  S Caccia; S Garattini
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 2.  Stereoisomers and drug toxicity. The value of single stereoisomer therapy.

Authors:  A K Scott
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 3.  In vitro analysis of metabolic predisposition to drug hypersensitivity reactions.

Authors:  R J Riley; J S Leeder
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.